Emphasis on Application (Hypertension, Angina, Heart Rhythm Management, and Others); Type (Oral and Intravenous); End-User (Hospitals, Clinics, Home Care Settings, and Ambulatory Surgical Centers); and Region/Country
The Bulk Drug market was valued at USD 360 Bn in 2021 and is expected to grow at a strong CAGR of around 12% during the forecast period (2022-2030). Bulk drugs are pharmaceutical ingredients that are used as starting materials to produce finished dosage forms such as tablets, capsules, injectables, and others. They are also known as active pharmaceutical ingredients (APIs) or bulk actives. The high cost of branded drugs has led to increasing demand for generic drugs, which are often cheaper. As a result, the demand for bulk drugs, which are used to manufacture generic drugs, has also increased. Further, the increasing healthcare expenditure by governments and private organizations has led to an increased demand for drugs, including bulk drugs.
Some of the major players operating in the market Dr. Reddy’s Laboratories Ltd.; Bayer AG; Cambrex Corporation; Teva Pharmaceutical Industries Ltd.; Johnson & Johnson Private Limited.; BASF SE; Novartis AG; and Pfizer Inc Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst type, the natural segment is expected to grow at a higher CAGR during the forecast period.”
Based on type, the market is segmented into antibiotics, sulpha drugs, vitamins, steroids, analgesics, and others. As per our analysis, the vitamin segment is expected to grow at a higher CAGR during the forecast period. Vitamins are essential components in the pharmaceutical industry. The growth of the segment is mainly driven by the rising demand for vitamin-based drugs as supplementary drugs in all diseases. Further, the vitamins are also used as excipients in other drugs to add high nutritional value to the drug.
“Amongst end-user, the oral segment held the dominant share in 2021.”
Based on the end-user, the market is segmented into pharmaceuticals, biotechnology, and veterinary medicine. As per our analysis, the pharmaceutical segment held the dominant share in 2021. Pharmaceutical companies manufacture bulk drugs at a large scale due to the increasing population and rising prevalence of chronic diseases in them are the main reasons responsible for the large share of the segment in the market.
Bulk Drug Market Report Coverage
“Asia Pacific is expected to grow with the highest CAGR Bulk Drug market during the forecast period.”
Asia Pacific is expected to grow with the highest CAGR Bulk drug market during the forecast period due to its large population and the increasing geriatric population in the region increasing demand for effective cheaper medicines in the region attributed to the market growth in the region. For instance, as per the European Parliament, Japan is aging rapidly. Its “aging” society is the oldest in the world, 28.7% of the population is over the age of 65 and women make up the majority.
Reasons to buy this report:
Customization Options:
The global Bulk drug market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
1. Market Introduction
2. Research Methodology Or Assumption
3. Market Synopsis
4. Executive Summary
5. Global Bulk Drug Market Covid-19 Impact
6. Global Bulk Drug Market Revenue, 2020-2028f
7. Market Insights By Type
8. Market Insights By End-use
9. Market Insights By Region
10. Bulk Drug Market Dynamics
11. Bulk Drug Market Opportunities
12. Bulk Drug Market Trends
13. Demand And Supply-side Analysis
14. Value Chain Analysis
15. Pricing Analysis
16. Strategic Insights
17. Competitive Scenario
18. Company Profiled
19. Disclaimer
Research Methodology for the Bulk Drug Market Analysis (2022-2030)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global Bulk drug market were the three major steps undertaken to create and analyze the adoption of bulk drugs in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global bulk drug market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the bulk drug market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the bulk drug market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as type and end-use. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the bulk drug market. Further, we conducted factor analysis using dependent and independent variables such as type and end-use of the bulk drug market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the Bulk Drug market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global Bulk Drug market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2030 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global Bulk Drug market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of the type, category, and application in the global bulk drug market.
The main objective of the Global bulk drug Market Study
The current & future market trends of the global Bulk Drug market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
